Showing results (941-950 of 959) with videos related to
Sort By:
Pageof 96
Cell Reports|December 16, 2020
Synthetic Lethal Interaction between the ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16qJasper E Neggers, Brenton R Paolella, Adhana Asfaw, et al.Journal of Clinical Immunology|August 10, 2022
Cryptococcus gattii Infection as the Major Clinical Manifestation in Patients with Autoantibodies Against Granulocyte-Macrophage Colony-Stimulating FactorShang-Yu Wang, Yu-Fang Lo, Han-Po Shih, et al.British Journal of Cancer|October 6, 2017
Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survivalVicente Morales-Oyarvide, Douglas A Rubinson, Richard F Dunne, et al.Lancet (London, England)|February 25, 2021
Improving lung health in low-income and middle-income countries: from challenges to solutionsJamilah Meghji, Kevin Mortimer, Alvar Agusti, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 10, 2023
Clinical practice consensus for the diagnosis and management of melanoma in TaiwanChiao-En Wu, Yi-Hua Liao, Cheng-Lin Wu, et al.Nature Medicine|September 29, 2014
Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma developmentJared R Mayers, Chen Wu, Clary B Clish, et al.Cancer Research|December 2, 2022
Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral HeterogeneityHannah L Williams, Andressa Dias Costa, Jinming Zhang, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 3, 2018
Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancerMatthew B Yurgelun, Anu B Chittenden, Vicente Morales-Oyarvide, et al.Gut|December 20, 2023
Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancerRoni Ben-Ami, Qiao-Li Wang, Jinming Zhang, et al.Nature Cancer|May 25, 2026
Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trialKimberly J Perez, Andressa Dias Costa, Alexander Jordan, et al.Pageof 96